研发费用加计扣除新政对企业绩效的影响研究——以乐普医疗为例

Research on the Impact of New Policy For R&D Expenses Deduction On Corporate Performance——Take Lepu Medical as an Example

为鼓励企业加大研发创新,进而提高经济效益,近期国家再度对研发费用加计扣除政策的修改做出决议,将扣除比例由50%提高到75%,且受惠主体扩大至所有企业。本文试图探索该新政是否促进了企业的研发投入,对企业绩效有何影响,并以乐普医疗为例进行案例分析。研究结果表明,研发费用加计扣除新政激励了企业加大研发投入,进而通过研发、生产及销售三个阶段对企业的财务绩效和创新绩效均产生了促进作用。

In order to encourage enterprises to increase R&D and innovation,and thereby increase economic efficiency,the State Council’s Standing Committee once again made a resolution on the revision of the R&D expense deduction policy,increasing the deduction ratio from 50%to 75%,and expanding the beneficiaries to all enterprises.This article attempts to explore whether the new R&D expense deduction policy has promoted R&D investment and what impact it has on corporate performance,and uses Lepu Medical as an example to conduct a case analysis.The research results show that the new policy for R&D expenses plus deduction has encouraged companies to increase R&D investment,and then promoted the financial performance and innovation performance of companies through three stages of R&D,production and sales.